Any of these blue chip stocks would be solid long-term picks. One of them, however, is especially underestimated right now.

Vertex Pharmaceuticals (VRTX 1.39%) is making its biggest bet in years. On Monday, the company agreed to acquire Crinetics ...

Its acquisition of Cursor demonstrates that it recognizes the importance of creating a robust AI platform -- but it also ...

SpaceX reached a multi-year deal with Alphabet that will average to $920 million per month, starting in October. SpaceX w ...

JPMorgan analyst Chris Schott reiterated his overweight (read: buy) rating on Eli Lilly's stock and boosted his share price ...

Shares of Figma (FIG +4.79%) were taking a dive last month as part of a broader pullback in software stocks amid ongoing fears of AI disruption, especially after Anthropic launche ...

Shares of Meta Platforms (META +2.59%) were heading lower last month as a slew of concerns mounted for the social media giant ...

Well before market open that day, Palantir reported that it had agreed to an "enterprise expansion agreement" with Mexico's ...

Micron stock has soared about 242% in 2026 as of this writing, and it crossed $1 trillion in market value along the way. A run like that doesn't happen unless the market is already counting on blowout ...

Based on Rivian’s closing price of $20.14 per share on July 6, the offering would raise slightly over $1.5 billion. Here’s ...

On June 12, Richtech divulged in a regulatory filing that the audit committee of its board of directors found that the ...

Microsoft (MSFT +0.59%) has a massive business with many products and services. And while its overall operations continue to ...